BioCentury
ARTICLE | Clinical News

Pill-Plus: Phase II data

September 15, 2008 7:00 AM UTC

In a double-blind Phase II trial, Pill-Plus was shown to restore testosterone levels to the normal range of 1.3 to 8.0 pg/mL for premenopausal healthy women. Pantarhei has rights to develop and commer...